Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Immunogen (IMGN)
(
)
Quote & Articles
Transcripts
Instablogs
Comments on articles
Cramer
Authors on IMGN
Newest on IMGN
M. E. Garza
(1)
The Burrill Report
(2)
J Clinton Hill
(1)
Dan Rosenblum
(1)
Beta Delta
(5)
Most frequent on IMGN
Ohad Hammer
(
16
)
Alan Brochstein
(
5
)
Beta Delta
(
5
)
Mike Havrilla
(
3
)
Simple Truths
(
2
)
Most followed on IMGN
Mike Havrilla
(
1086
)
Alan Brochstein
(
522
)
J Clinton Hill
(
379
)
Ohad Hammer
(
119
)
M. E. Garza
(
117
)
Most commented on IMGN
Ohad Hammer
(
40
)
Alan Brochstein
(
15
)
Beta Delta
(
8
)
J Clinton Hill
(
5
)
Mike Havrilla
(
3
)
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Articles on Immunogen (IMGN)
by
latest
|
most commented
Pharma M&A: Big Bonds and Small Deals
Jun 26
•
The Burrill Report
•
BMTI
,
CNSO.OB
,
AFPC
•
Comment!
|
Quick Read
A Healthy Dose of Funding for Pharma, Biotech
Jun 21
•
The Burrill Report
•
EDEN
,
GSK
,
DNDN
•
Comment!
|
Quick Read
Healthcare Stocks Continue to Rise
Jun 19
•
M. E. Garza
•
IMGN
,
MRGE
,
NVAX
•
Comment!
|
Quick Read
FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO
Jun 1
•
Mike Havrilla
•
BVTI.PK
,
ALTH
,
AZN
•
2 Comments
|
Quick Read
Top Biotech Picks for ASCO 2009 (Part II)
May 27
•
Ohad Hammer
•
CRGN
,
ARQL
,
EXEL
•
2 Comments
|
Quick Read
Clinical Trial Updates: Cancer Drugs in Focus as ASCO Approaches
May 18
•
Mike Havrilla
•
CRGN
,
AMGN
,
ALTH
•
1 Comment
|
Quick Read
FDA, Clinical Trial Calendar Updates: AstraZeneca Announces Phase III Results
May 12
•
Mike Havrilla
•
IMGN
,
DSCO
,
AZN
•
Comment!
|
Quick Read
Bright Prospects for Micromet (Part 2)
Apr 24
•
Ohad Hammer
•
IMGN
,
MEDX
,
MITI
•
3 Comments
|
Quick Read
Immunogen: Moving on Up
Mar 27
•
Beta Delta
•
IMGN
,
DNA
•
Comment!
|
Quick Read
Good News for Roche and Excellent News For Immunogen
Mar 20
•
Ohad Hammer
•
IMGN
,
DNA
,
RHHBY.PK
•
Comment!
|
Quick Read
20 'Bathwater Babies' and 3 'Dogs with Fleas' for the Week
Mar 2
•
J Clinton Hill
•
ALK
,
ALTH
,
AFAM
•
5 Comments
|
Quick Read
Genentech's Trastuzumab-Dm1 Shows Great Promise in Treating Breast Cancer
Jan 6
•
Beta Delta
•
IMGN
,
DNA
•
3 Comments
|
Quick Read
Immunogen and Exelixis Defy the Recession
Dec 22, 2008
•
Ohad Hammer
•
DNA
,
BMY
,
EXEL
•
Comment!
|
Quick Read
Time to Buy ImmunoGen
Dec 4, 2008
•
Beta Delta
•
IMGN
•
Comment!
|
Quick Read
Why It's Time to Buy More Immunogen
Oct 17, 2008
•
Ohad Hammer
•
IMGN
,
DNA
•
Comment!
|
Quick Read
Genentech's Decision Should Boost Immunogen Stock
Oct 15, 2008
•
Ohad Hammer
•
IMGN
,
DNA
•
Comment!
|
Quick Read
'When There's Blood in the Streets', Buy Biotech Stocks
Oct 10, 2008
•
Ohad Hammer
•
AMGN
,
ALTH
,
ALNY
•
13 Comments
|
Quick Read
Genentech’s New ADC Platform Has Much Potential, but Is Yet to Be Tested on Humans
Aug 6, 2008
•
Ohad Hammer
•
IMGN
,
DNA
,
SGEN
•
2 Comments
|
Quick Read
Immunogen's Wild Swings Due to Lack of Information at ASCO
Jul 14, 2008
•
Ohad Hammer
•
IMGN
,
DNA
,
SGEN
•
3 Comments
|
Quick Read
Immunogen and Seattle Genetics: Verging on an Inflection Point
May 27, 2008
•
Ohad Hammer
•
IMGN
,
CRGN
,
DNA
•
4 Comments
|
Quick Read
ASCO: Whose Presentations Look the Most Promising?
May 27, 2008
•
Dan Rosenblum
•
IMCL
,
ARIA
,
CELG
•
1 Comment
|
Quick Read
Why is Wall Street Ignoring ImmunoGen?
May 16, 2008
•
Beta Delta
•
IMGN
•
4 Comments
|
Quick Read
The Future of ImmunoGen - Care of Genentech
Mar 17, 2008
•
Beta Delta
•
IMGN
,
DNA
•
1 Comment
|
Quick Read
Micromet: Biting Cancer
Feb 6, 2008
•
Ohad Hammer
•
IMGN
,
MITI
,
SGEN
•
1 Comment
|
Quick Read
ImmunoGen at ASH 2007 (Part II)
Dec 30, 2007
•
Ohad Hammer
•
IMGN
•
Comment!
|
Quick Read
ImmunoGen at ASH 2007 (Part I)
Dec 30, 2007
•
Ohad Hammer
•
IMGN
•
1 Comment
|
Quick Read
PowerHouse Week for Economic Calendar
Oct 29, 2007
•
Michael Shaffer
•
ADP
,
ABN
,
AAP
•
1 Comment
|
Quick Read
Immunogen's Bright Future (Part II)
Oct 18, 2007
•
Ohad Hammer
•
IMGN
•
4 Comments
|
Quick Read
Immunogen’s Bright Future
Oct 9, 2007
•
Ohad Hammer
•
IMGN
•
4 Comments
|
Quick Read
The "Naked" Truth About Antibodies For Cancer Therapy
Jul 5, 2007
•
Ohad Hammer
•
DNA
,
AMGN
,
IMCL
•
3 Comments
|
Quick Read
Cancer Stocks Hammered Once Again
Jun 26, 2007
•
Alan Brochstein
•
AFFY
,
AGEN
,
ABPI
•
7 Comments
|
Quick Read
Cancer Stocks Slide Again
Jun 18, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
1 Comment
|
Quick Read
Super Results for Genentech/Immunogen's "Super-Herceptin" Collaboration
Jun 12, 2007
•
Simple Truths
•
IMGN
,
DNA
•
Comment!
|
Quick Read
Cancer Stocks Plunge Following ASCO Meeting
Jun 11, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
3 Comments
|
Quick Read
Cancer Stocks Soar With Annual ASCO Meeting
Jun 4, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
1 Comment
|
Quick Read
Cancer Stocks on the Go: Winners and Losers
May 29, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
3 Comments
|
Quick Read
Is Immunogen Helping to Build a 'Supercharged' Herceptin?
May 16, 2007
•
Simple Truths
•
IMGN
•
Comment!
|
Quick Read